(Q39470075)

12 September 2017

Dramatic response to levamisole and low-dose prednisolone in 23 patients with oral lichen planus: a 6-year prospective follow-up study (English)

1 reference

12 September 2017

1 reference

1 reference

1 reference

Lu SY

1

1 reference

12 September 2017

Chen WJ

series ordinal

2

1 reference

12 September 2017

Eng HL

series ordinal

3

1 reference

12 September 2017

language of work or name

1 reference

1 December 1995

1 reference

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

12 September 2017

1 reference

12 September 2017

80

1 reference

12 September 2017

6

1 reference

12 September 2017

705-709

1 reference

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2805%2980255-0

7 January 2021

Cellular immune modulation after a single high dose of Levamisole in patients with carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2805%2980255-0

7 January 2021

Levamisole in the treatment of erythema multiforme: a double-blind trial in fourteen patients

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2805%2980255-0

7 January 2021

Pemphigus vulgaris. A study of six cases treated with levamisole and prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2805%2980255-0

7 January 2021

Double-blind study of levamisole therapy in recurrent aphthous stomatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2805%2980255-0

7 January 2021

Letter: Levamisole in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2805%2980255-0

7 January 2021

Lichen planus: review and update on pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2805%2980255-0

7 January 2021

Potentiation by levamisole, methisoprinol, and adenine or adenosine of the inhibitory activity of human interferon against encephalomyocarditis virus

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2805%2980255-0

7 January 2021

The effect of levamisole on energy metabolism in Ehrlich ascites tumour cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2805%2980255-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1079-2104%2805%2980255-0

1 reference

7 January 2021

A prospective follow-up study of 570 patients with oral lichen planus: persistence, remission, and malignant association

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2805%2980255-0

7 January 2021

Course of various clinical forms of oral lichen planus. A prospective follow-up study of 611 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2805%2980255-0

7 January 2021

Adverse side effects associated with prednisone in the treatment of patients with oral inflammatory ulcerative diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2805%2980255-0

7 January 2021

Cyclosporin wash for oral lichen planus

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2805%2980255-0

7 January 2021

Effect of topical cyclosporine rinse on oral lichen planus. A double-blind analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2805%2980255-0

7 January 2021

Griseofulvin in the treatment of three cases of oral erosive lichen planus

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2805%2980255-0

7 January 2021

Griseofulvin therapy in lichen planus. A double-blind controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2805%2980255-0

7 January 2021

Levamisole and agranulocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2805%2980255-0

7 January 2021

Cellular immunosuppression in oral lichen planus

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2805%2980255-0

7 January 2021

Interferon activity and its characterization in the sera of patients with premalignant lesions arising in oral mucosa.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2805%2980255-0

7 January 2021

Use of levamisole in recurrent aphthous stomatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2805%2980255-0

7 January 2021

Letter: Levamisole in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2805%2980255-0

7 January 2021

Immunopathogenesis of oral lichen planus

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2805%2980255-0

7 January 2021

Phenotypic and functional analysis of peripheral blood lymphocytes in oral lichen planus.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2805%2980255-0

7 January 2021

Subsets of T lymphocytes in peripheral blood of patients with oral lichen planus

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2805%2980255-0

7 January 2021

10.1016/S1079-2104(05)80255-0

Identifiers

DOI

1 reference

release_hc3cf2ywvrgj7ddixm4xlb7n34

12 September 2017

0 references

1 reference